TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's
Teva - Updates, News, Events, Signals & Triggers
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals - Wikiwand
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back
Teva's CEO Kåre Schultz to retire at year end, succeeded by Richard Francis
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Drug maker Teva's U.S. unit indicted on price-fixing charges - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva's latest quarter was even worse than already-low expectations - MarketWatch
Teva Pharmaceutical Industries - Recent News & Activity
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
Teva's Battered Stock Looks Extremely Cheap | Barron's
Investors wary of Teva-Mylan merger - MarketWatch
Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7% - TheStreet
Teva Stock Sees Another Big Buy From Chairman Sol Barer | Barron's
